{"title":"2021年秘鲁利马18-29岁男男性行为者艾滋病毒暴露前预防意识的流行和探索:一项混合方法研究","authors":"Diego Tofeño, Diana Uypan, Paola Torres-Slimming","doi":"10.1016/j.cegh.2025.102099","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Pre-exposure prophylaxis (PrEP) is a therapeutic scheme that has shown effectiveness in reducing the risk of HIV infection through sexual contact. PrEP has been used in various countries globally and in Latin America as a public health measure. In Peru, the greatest increase in HIV incidence in recent years has occurred in the age group of 20–29 years and 15–19 years, this being an important range to be able to implement prevention measures.</div></div><div><h3>Objectives</h3><div>To determine the prevalence of awareness of HIV PrEP and to explore the knowledge and attitudes regarding its use among men who have sex with men (MSM) aged 18–29 years in Lima, Peru.</div></div><div><h3>Methods</h3><div>Explanatory sequential mixed method study whose central component is quantitative. A survey (non-probabilistic descriptive cross-sectional) and a virtual interview (phenomenological approach) were used for data collection.</div></div><div><h3>Results</h3><div>Of 100 seronegative MSM surveyed, 49 % were aware of PrEP. In the qualitative component, it was found that most participants obtained information casually through their social networks. It was also found that they had significant concern about the adverse effects of PrEP, which was mentioned as a barrier to its use.</div></div><div><h3>Conclusion</h3><div>Almost half of MSM are aware of the existence of PrEP, a medication that helps prevent HIV. However, it is important to find more reliable sources of information about PrEP because the fear of adverse effects and ignorance about it are limitations to its consumption.</div></div>","PeriodicalId":46404,"journal":{"name":"Clinical Epidemiology and Global Health","volume":"34 ","pages":"Article 102099"},"PeriodicalIF":2.3000,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prevalence and exploration of HIV pre-exposure prophylaxis awareness in men who have sex with men aged 18–29 years in Lima, Peru, during 2021: A mixed methods study\",\"authors\":\"Diego Tofeño, Diana Uypan, Paola Torres-Slimming\",\"doi\":\"10.1016/j.cegh.2025.102099\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Pre-exposure prophylaxis (PrEP) is a therapeutic scheme that has shown effectiveness in reducing the risk of HIV infection through sexual contact. PrEP has been used in various countries globally and in Latin America as a public health measure. In Peru, the greatest increase in HIV incidence in recent years has occurred in the age group of 20–29 years and 15–19 years, this being an important range to be able to implement prevention measures.</div></div><div><h3>Objectives</h3><div>To determine the prevalence of awareness of HIV PrEP and to explore the knowledge and attitudes regarding its use among men who have sex with men (MSM) aged 18–29 years in Lima, Peru.</div></div><div><h3>Methods</h3><div>Explanatory sequential mixed method study whose central component is quantitative. A survey (non-probabilistic descriptive cross-sectional) and a virtual interview (phenomenological approach) were used for data collection.</div></div><div><h3>Results</h3><div>Of 100 seronegative MSM surveyed, 49 % were aware of PrEP. In the qualitative component, it was found that most participants obtained information casually through their social networks. It was also found that they had significant concern about the adverse effects of PrEP, which was mentioned as a barrier to its use.</div></div><div><h3>Conclusion</h3><div>Almost half of MSM are aware of the existence of PrEP, a medication that helps prevent HIV. However, it is important to find more reliable sources of information about PrEP because the fear of adverse effects and ignorance about it are limitations to its consumption.</div></div>\",\"PeriodicalId\":46404,\"journal\":{\"name\":\"Clinical Epidemiology and Global Health\",\"volume\":\"34 \",\"pages\":\"Article 102099\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-06-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Epidemiology and Global Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2213398425001885\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Epidemiology and Global Health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213398425001885","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
Prevalence and exploration of HIV pre-exposure prophylaxis awareness in men who have sex with men aged 18–29 years in Lima, Peru, during 2021: A mixed methods study
Introduction
Pre-exposure prophylaxis (PrEP) is a therapeutic scheme that has shown effectiveness in reducing the risk of HIV infection through sexual contact. PrEP has been used in various countries globally and in Latin America as a public health measure. In Peru, the greatest increase in HIV incidence in recent years has occurred in the age group of 20–29 years and 15–19 years, this being an important range to be able to implement prevention measures.
Objectives
To determine the prevalence of awareness of HIV PrEP and to explore the knowledge and attitudes regarding its use among men who have sex with men (MSM) aged 18–29 years in Lima, Peru.
Methods
Explanatory sequential mixed method study whose central component is quantitative. A survey (non-probabilistic descriptive cross-sectional) and a virtual interview (phenomenological approach) were used for data collection.
Results
Of 100 seronegative MSM surveyed, 49 % were aware of PrEP. In the qualitative component, it was found that most participants obtained information casually through their social networks. It was also found that they had significant concern about the adverse effects of PrEP, which was mentioned as a barrier to its use.
Conclusion
Almost half of MSM are aware of the existence of PrEP, a medication that helps prevent HIV. However, it is important to find more reliable sources of information about PrEP because the fear of adverse effects and ignorance about it are limitations to its consumption.
期刊介绍:
Clinical Epidemiology and Global Health (CEGH) is a multidisciplinary journal and it is published four times (March, June, September, December) a year. The mandate of CEGH is to promote articles on clinical epidemiology with focus on developing countries in the context of global health. We also accept articles from other countries. It publishes original research work across all disciplines of medicine and allied sciences, related to clinical epidemiology and global health. The journal publishes Original articles, Review articles, Evidence Summaries, Letters to the Editor. All articles published in CEGH are peer-reviewed and published online for immediate access and citation.